The United States market has shown robust growth, with a 1.8% increase over the last week and a remarkable 28% rise over the past year, while earnings are projected to grow by 17% annually. In such an environment, identifying stocks that may be trading below their estimated value can offer investors potential opportunities for capitalizing on future growth.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name	Current Price	Fair Value (Est)	Discount (Est)
Uranium Energy (UEC)	$13.55	$26.26	48.4%
Reddit (RDDT)	$167.69	$323.76	48.2%
Live Oak Bancshares (LOB)	$37.62	$74.21	49.3%
Janus Living (JAN)	$27.54	$54.30	49.3%
Gilead Sciences (GILD)	$136.22	$266.88	49%
FB Financial (FBK)	$53.06	$101.61	47.8%
CoStar Group (CSGP)	$32.30	$62.00	47.9%
Bowhead Specialty Holdings (BOW)	$26.82	$52.60	49%
AXT (AXTI)	$115.70	$227.65	49.2%
AbbVie (ABBV)	$218.63	$417.90	47.7%

Below we spotlight a couple of our favorites from our exclusive screener.

Alkami Technology (ALKT)

Overview: Alkami Technology, Inc. offers a cloud-based digital sales and service platform for financial institutions in the United States, with a market cap of approximately $1.88 billion.

Operations: Alkami Technology generates revenue from its Internet Software & Services segment, totaling $471.94 million.

Estimated Discount To Fair Value: 42.5%

Alkami Technology is trading at US$17.59, significantly below its estimated future cash flow value of US$30.58, suggesting it is undervalued based on discounted cash flow analysis. The company expects to become profitable within three years, with earnings projected to grow substantially each year. However, recent insider selling and slower revenue growth compared to some benchmarks may warrant caution despite analyst consensus predicting a 23% rise in stock price.

Omada Health (OMDA)

Overview: Omada Health, Inc., along with its subsidiary Physera, Inc., offers virtual care programs in the United States and has a market cap of $978.52 million.

Operations: The company's revenue is derived entirely from its virtual care program product offerings, amounting to $283.30 million.

Estimated Discount To Fair Value: 36.9%

Omada Health trades at US$17.82, well below its estimated future cash flow value of US$28.24, highlighting potential undervaluation. The company expects profitability within three years, with earnings growth forecast at 95.77% annually, surpassing market averages. Recent developments include a partnership with Eli Lilly's Employer Connect program and strong Q1 2026 financials showing revenue growth and reduced net losses year-over-year, though return on equity remains low at a projected 7.1%.

Capri Holdings (CPRI)

Overview: Capri Holdings Limited is involved in the design, marketing, distribution, and retail of branded apparel, footwear, and accessories across various global regions with a market cap of approximately $2.10 billion.

Operations: Capri Holdings Limited generates its revenue through the creation, marketing, distribution, and sale of branded apparel, footwear, and accessories across diverse international markets.

Estimated Discount To Fair Value: 38.9%

Capri Holdings, trading at US$19.74, is significantly undervalued compared to its estimated future cash flow value of US$32.32. The company has returned to profitability with a net income of US$137 million for the full year. Although revenue growth is slow at 2.2% annually, earnings are expected to grow significantly at 25.3% per year, outpacing the market average. Recent share buybacks totaling US$79 million may further enhance shareholder value despite high debt levels and large one-off items affecting results.

Where To Now?

• Click here to access our complete index of 138 Undervalued US Stocks Based On Cash Flows.
• Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
• Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.

Want To Explore Some Alternatives?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.